ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2892

Persistently Frequent Emergency Department (ED) Utilization Among Systemic Lupus Erythematosus (SLE) Patients 

Jiha Lee1, Lisa Gale Suter1,2 and Liana Fraenkel1,3, 1Rheumatology, Rheumatology, Yale University School of Medicine, New Haven, CT, New Haven, CT, 2Medicine, Rheumatol., TAC S541, Rheumatology, VA Connecticut Healthcare System, West Haven, CT, New Haven, CT, 3Medicine, Section of Rheumatology, Rheumatology, VA Connecticut Healthcare System, West Haven, CT, New Haven, CT

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 8, 2017

Title: Health Services Research II: Methods and Technology in Care and Research

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: SLE patients frequently utilize the ED irrespective of their access to care, which raises concern for inadequate quality of care in the outpatient setting. In the general population, previous studies have shown that most high-utilizers only use the ED frequently for a brief period of time (<12 months), however, a subgroup continue to use the ED persistently over years. We sought to investigate the characteristics and patterns of healthcare resource utilization among SLE patients who persistently frequent the ED in order to identify opportunities to improve outpatient care.

Methods: We identified SLE patients who persistently frequented the ED from 2013-2016. Persistent use was defined as having 3 or more ED visits during the 12 months in a calendar year, for at least 2 out of the 4 years, consecutive or non-consecutive, during the study period. Patient demographics, general health status, SLE history, long-term opioid therapy (LOT), encounter specific information and disposition were collected through retrospective electronic health record review. Each ED encounter was categorized into the following groups; SLE-, infection-, pain-related, or other. We used multivariate logistic regression to evaluate patient characteristics associated with each encounter category group. Variables with p-value <0.1 in univariate analysis were included in the multivariate model.

Results: Seventy-seven SLE patients having 1143 encounters were identified as persistently frequent ED users. Most were female (91%) and had SLE for longer than 10 years (54%). The mean age was 42 (SD 15), and 69% were African American, 14% were Caucasian, and 17% were Hispanic. All had some form of insurance with 49% having Medicaid as their primary insurance. Approximately one third had diagnosis of depression (31%) and 38% were on LOT. Most were on hydroxychloroquine (77%) and/or an additional disease modifying rheumatic drug (51%). Of all ED encounters, 32% were pain-related (Figure 1), and of these most were either discharged from the ED (69%) or within 48 hours of admission (20%). In multivariate analysis, SLE patients with pain-related encounters accounting for >10% of ED use were more likely to be obese, have more comorbid conditions, and be on LOT (Table 1).

Conclusion: Pain is major cause of ED use among SLE patients, and associated with LOT. SLE patients who utilize the ED for pain are more likely to be non-critically ill, as evidenced by frequent discharges from the ED and short stay admissions. Thus, SLE patients who persistently frequent the ED for pain may represent a viable target for interventions to improve outpatient care and care co-ordination.


Disclosure: J. Lee, None; L. G. Suter, CMS, 3; L. Fraenkel, None.

To cite this abstract in AMA style:

Lee J, Suter LG, Fraenkel L. Persistently Frequent Emergency Department (ED) Utilization Among Systemic Lupus Erythematosus (SLE) Patients  [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/persistently-frequent-emergency-department-ed-utilization-among-systemic-lupus-erythematosus-sle-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/persistently-frequent-emergency-department-ed-utilization-among-systemic-lupus-erythematosus-sle-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology